Leder BZ - Search Results

1

Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.

Lee H, Finkelstein JS, Miller M, Comeaux SJ, Cohen RI, Leder BZ. Lee H, et al. Among authors: leder bz. J Clin Endocrinol Metab. 2006 Mar;91(3):1069-75. doi: 10.1210/jc.2005-2495. Epub 2005 Dec 13. J Clin Endocrinol Metab. 2006. PMID: 16352679

2

Oral androstenedione administration and serum testosterone concentrations in young men.

Leder BZ, Longcope C, Catlin DH, Ahrens B, Schoenfeld DA, Finkelstein JS. Leder BZ, et al. JAMA. 2000 Feb 9;283(6):779-82. doi: 10.1001/jama.283.6.779. JAMA. 2000. PMID: 10683057 Clinical Trial.

3

Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite.

Catlin DH, Leder BZ, Ahrens B, Starcevic B, Hatton CK, Green GA, Finkelstein JS. Catlin DH, et al. Among authors: leder bz. JAMA. 2000 Nov 22-29;284(20):2618-21. doi: 10.1001/jama.284.20.2618. JAMA. 2000. PMID: 11086369 Clinical Trial.

4

Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS. Leder BZ, et al. J Clin Endocrinol Metab. 2001 Feb;86(2):511-6. doi: 10.1210/jcem.86.2.7177. J Clin Endocrinol Metab. 2001. PMID: 11158001 Clinical Trial.

5

Metabolism of orally administered androstenedione in young men.

Leder BZ, Catlin DH, Longcope C, Ahrens B, Schoenfeld DA, Finkelstein JS. Leder BZ, et al. J Clin Endocrinol Metab. 2001 Aug;86(8):3654-8. doi: 10.1210/jcem.86.8.7705. J Clin Endocrinol Metab. 2001. PMID: 11502792 Clinical Trial.

6

Effects of androstenedione administration on epitestosterone metabolism in men.

Catlin DH, Leder BZ, Ahrens BD, Hatton CK, Finkelstein JS. Catlin DH, et al. Among authors: leder bz. Steroids. 2002 Jun;67(7):559-64. doi: 10.1016/s0039-128x(02)00005-3. Steroids. 2002. PMID: 11996927 Clinical Trial.

7

Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.

Leder BZ, Leblanc KM, Longcope C, Lee H, Catlin DH, Finkelstein JS. Leder BZ, et al. J Clin Endocrinol Metab. 2002 Dec;87(12):5449-54. doi: 10.1210/jc.2002-021035. J Clin Endocrinol Metab. 2002. PMID: 12466335 Clinical Trial.

8

Differential effects of androgens and estrogens on bone turnover in normal men.

Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Leder BZ, et al. J Clin Endocrinol Metab. 2003 Jan;88(1):204-10. doi: 10.1210/jc.2002-021036. J Clin Endocrinol Metab. 2003. PMID: 12519853 Clinical Trial.

9

Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.

Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C. Leder BZ, et al. J Clin Endocrinol Metab. 2004 Mar;89(3):1174-80. doi: 10.1210/jc.2003-031467. J Clin Endocrinol Metab. 2004. PMID: 15001605 Clinical Trial.

10

Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.

Dougherty RH, Rohrer JL, Hayden D, Rubin SD, Leder BZ. Dougherty RH, et al. Among authors: leder bz. Clin Endocrinol (Oxf). 2005 Feb;62(2):228-35. doi: 10.1111/j.1365-2265.2005.02205.x. Clin Endocrinol (Oxf). 2005. PMID: 15670201 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters